loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Pentetate Indium Disodium In 111 Usan, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Pentetate Indium Disodium In 111 Usan

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: 60662-14-8, Pentetate indium disodium in 111, 7uit3zgc8e, Pentetate indium disodium in 111 [usan], Disodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))indate(2-)-(sup 111)in, Disodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;indium-111(3+)
    Molecular Formula
    C14H18InN3Na2O10
    Molecular Weight
    545.19  g/mol
    InChI Key
    JKGXLBAWNSPIFF-LWQDMHIUSA-I
    FDA UNII
    7UIT3ZGC8E
    Indium in-111 pentetate disodium is a Radioactive Diagnostic Agent. The mechanism of action of indium in-111 pentetate disodium is as a Radiopharmaceutical Activity.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    disodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;indium-111(3+)
    2.1.2 InChI
    InChI=1S/C14H23N3O10.In.2Na/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;/q;+3;2*+1/p-5/i;1-4;;
    2.1.3 InChI Key
    JKGXLBAWNSPIFF-LWQDMHIUSA-I
    2.1.4 Canonical SMILES
    C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[In+3]
    2.1.5 Isomeric SMILES
    C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[111In+3]
    2.2 Other Identifiers
    2.2.1 UNII
    7UIT3ZGC8E
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 60662-14-8

    2. Pentetate Indium Disodium In 111

    3. 7uit3zgc8e

    4. Pentetate Indium Disodium In 111 [usan]

    5. Disodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))indate(2-)-(sup 111)in

    6. Disodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;indium-111(3+)

    7. Pentetate Indium Disodium In 111 (usan)

    8. Unii-7uit3zgc8e

    9. Indium Dtpa In 111 (tn)

    10. Pentetate Indium Disodium In-111

    11. Pentetate Indium Disodium,in-111

    12. Dtxsid101027591

    13. Indium (in111) Disodium Pentetate

    14. Pentetate Indium Disodium, In-111

    15. D05421

    16. Pentetate Indium Disodium,in-111 [vandf]

    17. Indium (111 In) Disodium Pentetate [who-dd]

    18. Q27268870

    19. Indium In-111 Pentetate Disodium [orange Book]

    20. Disodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))indate(2-)-111in

    21. Indate(2-)-(sup 111)in-, (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, Disodium

    2.4 Create Date
    2008-02-08
    3 Chemical and Physical Properties
    Molecular Weight 545.19 g/mol
    Molecular Formula C14H18InN3Na2O10
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count13
    Rotatable Bond Count11
    Exact Mass544.98386 g/mol
    Monoisotopic Mass544.98386 g/mol
    Topological Polar Surface Area210 Ų
    Heavy Atom Count30
    Formal Charge0
    Complexity454
    Isotope Atom Count1
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count4
    4 Pharmacology and Biochemistry
    4.1 FDA Pharmacological Classification
    4.1.1 Active Moiety
    INDIUM IN-111 PENTETATE DISODIUM
    4.1.2 FDA UNII
    7UIT3ZGC8E
    4.1.3 Pharmacological Classes
    Mechanisms of Action [MoA] - Radiopharmaceutical Activity
    Post Enquiry
    POST ENQUIRY